CooperCompanies (COO) reported financial results for the fourth quarter and fiscal year ended October 31, 2025, showing modest revenue growth but a decline in GAAP earnings from the comparable period.
The San Ramon, California-based medical device company operates through two divisions - CooperVision and CooperSurgical.
Fourth quarter 2025 Results:
Revenue for the fourth quarter of 2025 rose to $1,065.2 million, up 5% from 1,018.4 million in Q4 2024.
The CooperVision segment contributed the largest share, delivering $709.6 million, up 5% from $676.4 million in Q4 2024. The CooperSurgical segment generated $355.6 million in revenue, representing a 4% rise from $342.0 million a year earlier.
GAAP net income for Q4, 2025, was $84.6 million, or $0.43 per share, down from $117.5 million, or $0.58 per share, in Q4 2024. Non-GAAP net income rose to $228.3 million, or $1.15 per share, compared to $208.5 million, or $1.04 a year earlier.
Gross margin slipped to 61% in Q4, 2025, from 67% in Q4 2024, reflecting organisational costs.
Free cash flow improved to $149.8 million, compared to $128.2 million in Q4 2024.
Fiscal Year 2025 Results:
Total revenue reached $4,092.4 million, up 5% from $3,895.4 million in fiscal 2024.
GAAP diluted EPS declined to $1.87, down 4% from $1.96 in fiscal 2024.
Non-GAAP diluted EPS rose to $4.12, up 12% from $3.69 in fiscal 2024.
Free cash flow improved to $433.7 million, compared to $288.1 million in fiscal 2024.
Outlook
Looking ahead, CooperCompanies expects fiscal 2026 revenue to range between $4,299 million and $4,338 million, representing an increase of about 5-6% compared to the $4,092.4 million achieved in fiscal 2025.
Non-GAAP EPS for fiscal 2026 is expected to be $4.45 to $4.60, an increase of roughly 8-11% compared to $4.13 in FY25, highlighting management's expectation of continued earnings growth supported by reorganisation savings.
Separately, CooperCompanies announced today that Robert Weiss has been appointed Chair of the Board. The company also disclosed that its Board has initiated a strategic review process to evaluate opportunities for enhancing shareholder value.
COO closed yesterday's trading at $77.03, up 1.38%, and rose further during the overnight trading session to $85.10, up 10.48%. Trading volume came in at roughly 4.9 million shares versus an average volume of 2.6 million shares. Over the past 12 months the stock has traded between $61.78 and $101.53.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.